North America Testosterone Replacement Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2022

November 2017 | 117 pages | ID: N8DE1D41D10EN
GlobalInfoResearch

Abstracts

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.

Scope of the Report:

This report focuses on the Testosterone Replacement Therapy in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• AbbVie
• Endo International
• Eli lilly
• Pfizer
• Actavis (Allergan)
• Bayer
• Novartis
• Teva
• Mylan
• Upsher-Smith
• Ferring Pharmaceuticals
• Kyowa Kirin
• Acerus Pharmaceuticals

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Gels
• Injections
• Patches
• Other

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Others

There are 15 Chapters to deeply display the North America Testosterone Replacement Therapy market.

Chapter 1, to describe Testosterone Replacement Therapy Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Testosterone Replacement Therapy, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Testosterone Replacement Therapy, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Testosterone Replacement Therapy market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Testosterone Replacement Therapy Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Testosterone Replacement Therapy Introduction
1.2 Market Analysis by Type
  1.2.1 Gels
  1.2.2 Injections
  1.2.3 Patches
  1.2.4 Other
1.3 Market Analysis by Applications
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Others
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 AbbVie
  2.1.1 Profile
  2.1.2 Testosterone Replacement Therapy Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 AbbVie Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 AbbVie News
2.2 Endo International
  2.2.1 Profile
  2.2.2 Testosterone Replacement Therapy Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Endo International Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Endo International News
2.3 Eli lilly
  2.3.1 Profile
  2.3.2 Testosterone Replacement Therapy Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Eli lilly Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Eli lilly News
2.4 Pfizer
  2.4.1 Profile
  2.4.2 Testosterone Replacement Therapy Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Pfizer Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Pfizer News
2.5 Actavis (Allergan)
  2.5.1 Profile
  2.5.2 Testosterone Replacement Therapy Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 Actavis (Allergan) News
2.6 Bayer
  2.6.1 Profile
  2.6.2 Testosterone Replacement Therapy Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Bayer Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Bayer News
2.7 Novartis
  2.7.1 Profile
  2.7.2 Testosterone Replacement Therapy Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Novartis Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Novartis News
2.8 Teva
  2.8.1 Profile
  2.8.2 Testosterone Replacement Therapy Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Teva Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Teva News
2.9 Mylan
  2.9.1 Profile
  2.9.2 Testosterone Replacement Therapy Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Mylan Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.9.4 Business Overview
  2.9.5 Mylan News
2.10 Upsher-Smith
  2.10.1 Profile
  2.10.2 Testosterone Replacement Therapy Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.10.4 Business Overview
  2.10.5 Upsher-Smith News
2.11 Ferring Pharmaceuticals
  2.11.1 Profile
  2.11.2 Testosterone Replacement Therapy Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.11.4 Business Overview
  2.11.5 Ferring Pharmaceuticals News
2.12 Kyowa Kirin
  2.12.1 Profile
  2.12.2 Testosterone Replacement Therapy Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.12.4 Business Overview
  2.12.5 Kyowa Kirin News
2.13 Acerus Pharmaceuticals
  2.13.1 Profile
  2.13.2 Testosterone Replacement Therapy Type and Applications
    2.13.2.1 Type
    2.13.2.2 Type
  2.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.13.4 Business Overview
  2.13.5 Acerus Pharmaceuticals News

3 NORTH AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET COMPETITION, BY MANUFACTURER

3.1 North America Testosterone Replacement Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Testosterone Replacement Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Testosterone Replacement Therapy Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Testosterone Replacement Therapy Manufacturer Market Share
  3.4.2 Top 5 Testosterone Replacement Therapy Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA TESTOSTERONE REPLACEMENT THERAPY MARKET ANALYSIS BY COUNTRIES

4.1 North America Testosterone Replacement Therapy Sales Market Share by Countries
4.2 North America Testosterone Replacement Therapy Sales by Countries (2012-2017)
4.3 North America Testosterone Replacement Therapy Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION TESTOSTERONE REPLACEMENT THERAPY BY TYPE

5.1 North America Testosterone Replacement Therapy Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Testosterone Replacement Therapy Sales and Market Share by Type (2012-2017)
  5.1.2 North America Testosterone Replacement Therapy Revenue and Market Share by Type (2012-2017)
5.2 Gels Sales Growth and Price
  5.2.1 North America Gels Sales Growth (2012-2017)
  5.2.2 North America Gels Price (2012-2017)
5.3 Injections Sales Growth and Price
  5.3.1 North America Injections Sales Growth (2012-2017)
  5.3.2 North America Injections Price (2012-2017)
5.4 Patches Sales Growth and Price
  5.4.1 North America Patches Sales Growth (2012-2017)
  5.4.2 North America Patches Price (2012-2017)
5.5 Other Sales Growth and Price
  5.5.1 North America Other Sales Growth (2012-2017)
  5.5.2 North America Other Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION TESTOSTERONE REPLACEMENT THERAPY BY APPLICATION

6.1 North America Testosterone Replacement Therapy Sales Market Share by Application (2012-2017)
6.2 Hospitals Sales Growth (2012-2017)
6.3 Clinics Sales Growth (2012-2017)
6.4 Others Sales Growth (2012-2017)

7 UNITED STATES TESTOSTERONE REPLACEMENT THERAPY SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Testosterone Replacement Therapy Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Testosterone Replacement Therapy Sales and Market Share by Type
7.3 United States Testosterone Replacement Therapy Sales by Application (2012-2017)
7.4 United States Testosterone Replacement Therapy Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Testosterone Replacement Therapy Sales and Market Share by Manufacturer
  7.4.2 United States Testosterone Replacement Therapy Revenue and Market Share by Manufacturer
7.5 United States Testosterone Replacement Therapy Export and Import (2012-2017)

8 CANADA TESTOSTERONE REPLACEMENT THERAPY SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Testosterone Replacement Therapy Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Testosterone Replacement Therapy Sales and Market Share by Type
8.3 Canada Testosterone Replacement Therapy Sales by Application (2012-2017)
8.4 Canada Testosterone Replacement Therapy Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Testosterone Replacement Therapy Sales and Market Share by Manufacturer
  8.4.2 Canada Testosterone Replacement Therapy Revenue and Market Share by Manufacturer
8.5 Canada Testosterone Replacement Therapy Export and Import (2012-2017)

9 MEXICO TESTOSTERONE REPLACEMENT THERAPY SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Testosterone Replacement Therapy Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Testosterone Replacement Therapy Sales and Market Share by Type
9.3 Mexico Testosterone Replacement Therapy Sales by Application (2012-2017)
9.4 Mexico Testosterone Replacement Therapy Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Testosterone Replacement Therapy Sales and Market Share by Manufacturer
  9.4.2 Mexico Testosterone Replacement Therapy Revenue and Market Share by Manufacturer
9.5 Mexico Testosterone Replacement Therapy Export and Import (2012-2017)

10 TESTOSTERONE REPLACEMENT THERAPY MARKET FORECAST (2017-2022)

10.1 North America Testosterone Replacement Therapy Sales, Revenue and Growth Rate (2017-2022)
10.2 Testosterone Replacement Therapy Market Forecast by Countries (2017-2022)
  10.2.1 United States Testosterone Replacement Therapy Forecast (2017-2022)
  10.2.2 Canada Testosterone Replacement Therapy Forecast (2017-2022)
  10.2.3 Mexico Testosterone Replacement Therapy Forecast (2017-2022)
10.3 Testosterone Replacement Therapy Market Forecast by Type (2017-2022)
10.4 Testosterone Replacement Therapy Market Forecast by Application (2017-2022)

11 TESTOSTERONE REPLACEMENT THERAPY MANUFACTURING COST ANALYSIS

11.1 Testosterone Replacement Therapy Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Testosterone Replacement Therapy

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Testosterone Replacement Therapy Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Testosterone Replacement Therapy Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Testosterone Replacement Therapy Picture
Table Product Specifications of Testosterone Replacement Therapy
Figure North America Sales Market Share of Testosterone Replacement Therapy by Type